Skip to content

Clinical trials

Scleroderma, Systemic trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Scleroderma, Systemic Country / region: Japan Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20153
20172
20192
20211
20224
20232
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Active, not recruiting2
Recruiting2
Not yet recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim3
Kyowa Kirin Co., Ltd.2
Amgen1
AstraZeneca1
Bayer1
Benesis Corporation1
GlaxoSmithKline1
Hoffmann-La Roche1
Janssen Pharmaceutical K.K.1
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Scleroderma, Systemic17
Scleroderma, Diffuse3
Autoimmune Diseases2
Lung Diseases, Interstitial2
Collagen Diseases1
Immune System Diseases1
Intestinal Pseudo-Obstruction1
Pulmonary Fibrosis1

Trials

Showing 26 to 17 of 17. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.